Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Montserrat Garrigó

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|July 7, 2007
Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamideLina Marcela Aragón, Montserrat Garrigó, Carmen Moreno, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2006
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarraysLina Marcela Aragón, Ferran Navarro, Volker Heiser, et al.
Plos One|October 9, 2015
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus ComplexMarc Rubio, Francesca March, Montserrat Garrigó, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 20, 2011
[Use of different PCR-based techniques integrated into a non-tuberculous identification algorithm]Óscar Esparcia, Montserrat Español, Montserrat Garrigó, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 25, 2005
Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from BarcelonaPere Coll, Lina Marcela Aragón, Fernando Alcaide, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European cityVirginia Pomar, Montserrat Garrigó, Marc Colomé, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 2, 2024
Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluationCarles Alonso-Tarrés, Carla Benjumea Moreno, Ferran Navarro, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing <i>Mycobacterium avium</i>-<i>intracellulare</i> Complex Causing Chronic Pulmonary InfectionsElena Portell-Buj, Cecibel González-Criollo, Alexandre López-Gavín, et al.
Journal of Clinical Microbiology|April 20, 2007
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosisMontserrat Garrigó, Lina Marcela Aragón, Fernando Alcaide, et al.
Frontiers in Microbiology|March 26, 2025
Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencingMarc Rubio, Mariana Fernandez-Pittol, Sara Batista, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|July 7, 2007
Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamideLina Marcela Aragón, Montserrat Garrigó, Carmen Moreno, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2006
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarraysLina Marcela Aragón, Ferran Navarro, Volker Heiser, et al.
Plos One|October 9, 2015
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus ComplexMarc Rubio, Francesca March, Montserrat Garrigó, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 20, 2011
[Use of different PCR-based techniques integrated into a non-tuberculous identification algorithm]Óscar Esparcia, Montserrat Español, Montserrat Garrigó, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 25, 2005
Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from BarcelonaPere Coll, Lina Marcela Aragón, Fernando Alcaide, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European cityVirginia Pomar, Montserrat Garrigó, Marc Colomé, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 2, 2024
Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluationCarles Alonso-Tarrés, Carla Benjumea Moreno, Ferran Navarro, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing <i>Mycobacterium avium</i>-<i>intracellulare</i> Complex Causing Chronic Pulmonary InfectionsElena Portell-Buj, Cecibel González-Criollo, Alexandre López-Gavín, et al.
Journal of Clinical Microbiology|April 20, 2007
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosisMontserrat Garrigó, Lina Marcela Aragón, Fernando Alcaide, et al.
Frontiers in Microbiology|March 26, 2025
Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencingMarc Rubio, Mariana Fernandez-Pittol, Sara Batista, et al.
Pageof 2